Hoth Therapeutics, Inc. — Director's Dealing 2020

Feb 14, 2020

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-12-31

Reporting Person: Hayes Anthony (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-28	Common Stock	J	90258	—	Disposed	1609742	Indirect
2019-10-28	Common Stock	J	301	—	Acquired	105301	Direct
2019-11-08	Common Stock	J	9226	—	Disposed	1600516	Indirect

Footnotes

F1: On October 28, 2019, Spherix Incorporated ("Spherix") distributed shares of the Issuer's common stock on a pro rata basis to its stockholders of record as of October 21, 2019 (the "Record Date"). Stockholders of Spherix received 1 share of the Issuer's common stock for each 29 shares of Spherix common stock held by such stockholders as of the Record Date.

F2: 1,636,230 shares of the Issuer's common stock are owned by Spherix as of December 31, 2019. Anthony Hayes is the Chief Executive Officer and a member of the board of directors of Spherix. However, the board of directors of Spherix (with Mr. Hayes abstaining) appointed a committee that does not include Mr. Hayes to exercise voting and dispositive power over the securities held by such Spherix. As such, Mr. Hayes does not have voting and dispositive power over the shares held by Spherix.